Latest FDA Changes to the Process Bullet Proof 510k - 2017
There are three types of Premarket Notification 510(k)s that may be submitted to FDA: Traditional, Special, and Abbreviated. The Special and Abbreviated 510(k) methods were developed under the "New 510(k) Paradigm" to help streamline the 510(k) review process.
Product modifications that could significantly affect safety and effectiveness are subject to 510(k) submission requirements under 21 CFR 807 as well as design control requirements under the Quality System (QS) regulation. Under the QS regulation, all Class II and III devices and certain Class I devices are required to be designed in conformance to 21 CFR 820.30 Design Controls. FDA provides guidance and this course will address key resources when making critical decisions.
Objectives:
- Know the differences between the Traditional, Special and Abbreviated submissions
- Understand Substantial Equivalence and how it is applied
- Who is required to submit the application to FDA
- Where to submit the 510(k) and what to expect with the review and approval process
- When it is and is not required if you are a device company
- Exemptions to the submission process and special considerations
- How to locate a "predicate" device and go through the content and format of the 510(k)
- Understand the De Novo process and the expectations for possibly marketing a low risk device
- Understand the potential impact of FDA's proposed changes to the 510(k) process and why manufacturers need to pay attention
Who Will Benefit:
This course is appropriate to those involved in all aspects of the premarket notification, i.e., 510(k) process on behalf of medical device and In Vitro Diagnostic manufacturers. It is both a primer for personnel new to the FDA 510(k) process, or an excellent refresher course for those who need to revisit the basics and fundamentals for a better understanding on how to prepare and submit your application to ensure regulatory and compliance success. Those who will benefit include professionals in R&D, development, quality assurance and quality control, production, operations, engineering, compliance, and regulatory affairs and all levels of management, including technical and laboratory personnel who desire to understand what it takes to prepare and submit a bulletproof 510(k) to FDA while at the same time are aware of the changing regulatory landscape regarding FDA's proposed changes to the 510(k) process.
Speaker and Presenter Information
David R. Dills,Global Regulatory Affairs & Compliance Consultant currently provides regulatory affairs and compliance consultative services for early-stage and established Class I/II/III device, IVD, biopharmaceutical, cosmetics and nutraceutical manufacturers on the global landscape, and has an accomplished record with more than 27 years of experience in the areas of Regulatory Affairs, Compliance and Quality Systems.
Relevant Government Agencies
FDA Changes
Event Type
Webcast
This event has no exhibitor/sponsor opportunities
When
Tue, Jul 25, 2017, 10:00am - 11:00am
PT
Cost
General Admission: | $150.00 |
Website
Click here to visit event website
Organizer
NetZealous - Compliance4All